Related references
Note: Only part of the references are listed.Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation
Junjie Li et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Microbiome analysis combined with targeted metabolomics reveal immunological anti-tumor activity of icariside I in a melanoma mouse model
Gui Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
The therapeutic potential of targeting tryptophan catabolism in cancer
Christiane A. Opitz et al.
BRITISH JOURNAL OF CANCER (2020)
p27 as a Transcriptional Regulator: New Roles in Development and Cancer
Seyedeh Fatemeh Razavipour et al.
CANCER RESEARCH (2020)
Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy
Michael Cerezo et al.
CELL DEATH & DISEASE (2020)
Bioavailability and health benefits of major isoflavone aglycones and their metabolites
Yu-Hsuan Hsiao et al.
JOURNAL OF FUNCTIONAL FOODS (2020)
A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma
Lisa Greene et al.
MOLECULAR CANCER RESEARCH (2019)
Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
Xiaoyun Li et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Michael Platten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Icaritin promotes tumor T-cell infiltration and induces antitumor immunity in mice
Haibang Hao et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1)
Ute F. Rohrig et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis
Brian W. Labadie et al.
CLINICAL CANCER RESEARCH (2019)
Tumor-Repopulating Cells Induce PD-1 Expression in CD8(+) T Cells by Transferring Kynurenine and AhR Activation
Yuying Liu et al.
CANCER CELL (2018)
Inhibition Mechanisms of Human Indoleamine 2,3 Dioxygenase 1
Ariel Lewis-Ballester et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities
Jae Eun Cheong et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Characterization of a alpha-L-rhamnosidase from Bacteroides thetaiotaomicron with high catalytic efficiency of epimedin C
Tao Wu et al.
BIOORGANIC CHEMISTRY (2018)
Mapping the Binding Trajectory of a Suicide Inhibitor in Human Indoleamine 2,3-Dioxygenase 1
Khoa N. Pham et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Jason J. Luke et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health
Igor Cervenka et al.
SCIENCE (2017)
Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells
Yuying Liu et al.
NATURE COMMUNICATIONS (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice
Feng Sun et al.
CARCINOGENESIS (2016)
The AhR is involved in the regulation of LoVo cell proliferation through cell cycle-associated proteins
Jiuheng Yin et al.
CELL BIOLOGY INTERNATIONAL (2016)
Targeting T Cell Co-receptors for Cancer Therapy
Margaret K. Callahan et al.
IMMUNITY (2016)
LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain
Rene Fuertig et al.
BIOANALYSIS (2016)
An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells
Olga Novikov et al.
MOLECULAR PHARMACOLOGY (2016)
Activation of endoplasmic reticulum stress is involved in the activity of icariin against human lung adenocarcinoma cells
Shouyin Di et al.
APOPTOSIS (2015)
Icariside II-induced mitochondrion and lysosome mediated apoptosis is counterbalanced by an autophagic salvage response in hepatoblastoma
Ya-di Geng et al.
CANCER LETTERS (2015)
Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells
Muhammad Khan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2015)
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3
Shicong Zhu et al.
ONCOTARGET (2015)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Iain A. Murray et al.
NATURE REVIEWS CANCER (2014)
Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
Stefani Spranger et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita et al.
NATURE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives
Jessica Godin-Ethier et al.
CLINICAL CANCER RESEARCH (2011)
The genus Epimedium: An ethnopharmacological and phytochemical review
Huiping Ma et al.
JOURNAL OF ETHNOPHARMACOLOGY (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Kynurenic Acid Is a Potent Endogenous Aryl Hydrocarbon Receptor Ligand that Synergistically Induces Interleukin-6 in the Presence of Inflammatory Signaling
Brett C. DiNatale et al.
TOXICOLOGICAL SCIENCES (2010)
Cyclooxygenase-2/prostaglandin E2 pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells
Keun-Sung Lee et al.
CANCER LETTERS (2009)
TNFR1 signaling and IFN-γ signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis
Nele Mueller-Hermelink et al.
CANCER CELL (2008)
Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells
A Okamoto et al.
CLINICAL CANCER RESEARCH (2005)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
Share Paper
